Michael Thase

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Phenomena

Recurrence

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Thase Michael E
Does concomitant antidepressant therapy enhance response to electroconvulsive therapy?
Thase Michael E
Atypical depression: useful concept, but it's time to revise the DSM-IV criteria.
Kocsis James H; Gelenberg Alan J; Rothbaum Barbara O; Klein Daniel N; Trivedi Madhukar H; Manber Rachel; Keller Martin B; Leon Andrew C; Wisniewski Steven R; Arnow Bruce A; Markowitz John C; Thase Michael E;
Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Michael Thase (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Thase Michael E
Does concomitant antidepressant therapy enhance response to electroconvulsive therapy?
Current psychiatry reports 2009;11(6):423-5.
2009: Thase Michael E
Atypical depression: useful concept, but it's time to revise the DSM-IV criteria.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(13):2633-41.
2009: Kocsis James H; Gelenberg Alan J; Rothbaum Barbara O; Klein Daniel N; Trivedi Madhukar H; Manber Rachel; Keller Martin B; Leon Andrew C; Wisniewski Steven R; Arnow Bruce A; Markowitz John C; Thase Michael E;
Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.
Archives of general psychiatry 2009;66(11):1178-88.
2009: Soares Claudio N; Kornstein Susan G; Thase Michael E; Jiang Qin; Guico-Pabia Christine J
Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials.
The Journal of clinical psychiatry 2009;70(10):1365-71.
2009: Thase Michael E
Diagnosis and treatment of a major depressive episode.
The Journal of clinical psychiatry 2009;70(10):e37.
2009: Thase Michael E
Rapid improvement in affective information processing after acute administration of reboxetine.
The American journal of psychiatry 2009;166(10):1096-9.
2009: Maddux Rachel E; Riso Lawrence P; Klein Daniel N; Markowitz John C; Rothbaum Barbara O; Arnow Bruce A; Manber Rachel; Blalock Janice A; Keitner Gabor I; Thase Michael E
Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination.
Journal of affective disorders 2009;117(3):174-9.
2009: Goodman David W; Thase Michael E
Recognizing ADHD in adults with comorbid mood disorders: implications for identification and management.
Postgraduate medicine 2009;121(5):20-30.
2009: Thase Michael E
Newer medications for complicated depression.
The Journal of clinical psychiatry 2009;70(9):e33.
2009: Rydén E; Thase M E; Stråht D; Aberg-Wistedt A; Bejerot S; Landén M
A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD.
Acta psychiatrica Scandinavica 2009;120(3):239-46.
2009: Zisook Sidney; Trivedi Madhukar H; Warden Diane; Lebowitz Barry; Thase Michael E; Stewart Jonathan W; Moutier Christine; Fava Maurizio; Wisniewski Stephen R; Luther James; Rush A John
Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study.
Journal of affective disorders 2009;117(1-2):63-73.
2009: Fava Maurizio; Wisniewski Stephen R; Thase Michael E; Baker Ross A; Tran Quynh-Van; Pikalov Andrei; Yang Huyuan; Marcus Ronald N; Berman Robert M
Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studies.
Journal of clinical psychopharmacology 2009;29(4):362-7.
2009: Koenig Aaron M; Thase Michael E
First-line pharmacotherapies for depression - what is the best choice?
Polskie archiwum medycyny wewn?trznej 2009;119(7-8):478-86.
2009: Kupfer David J; Axelson David A; Birmaher Boris; Brown Charlotte; Curet David E; Fagiolini Andrea; Frank Ellen; Friedman Edward S; Grochocinski Victoria J; Houck Patricia R; Kilbourne Amy M; Mulsant Benoit H; Pollock Bruce G; Reynolds Charles F; Stofko Mary G; Swartz Holly A; Thase Michael E; Turkin Scott R; Whyte Ellen M
Bipolar disorder center for Pennsylvanians: implementing an effectiveness trial to improve treatment for at-risk patients.
Psychiatric services (Washington, D.C.) 2009;60(7):888-97.
2009: Perlis Roy H; Dennehy Ellen B; Miklowitz David J; Delbello Melissa P; Ostacher Michael; Calabrese Joseph R; Ametrano Rebecca M; Wisniewski Stephen R; Bowden Charles L; Thase Michael E; Nierenberg Andrew A; Sachs Gary
Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study.
Bipolar disorders 2009;11(4):391-400.
2009: Fagiolini Andrea; Frank Ellen; Axelson David A; Birmaher Boris; Cheng Yu; Curet David E; Friedman Edward S; Gildengers Ariel G; Goldstein Tina; Grochocinski Victoria J; Houck Patricia R; Stofko Mary G; Thase Michael E; Thompson Wesley K; Turkin Scott R; Kupfer David J
Enhancing outcomes in patients with bipolar disorder: results from the Bipolar Disorder Center for Pennsylvanians Study.
Bipolar disorders 2009;11(4):382-90.
2009: Perahia David G S; Maina Giuseppe; Thase Michael E; Spann Melissa E; Wang Fujun; Walker Daniel J; Detke Michael J
Duloxetine in the prevention of depressive recurrences: a randomized, double-blind, placebo-controlled trial.
The Journal of clinical psychiatry 2009;70(5):706-16.
2009: Thase Michael E
Evaluating atypical antipsychotics in the treatment of refractory depression.
The Journal of clinical psychiatry 2009;70(5):e14.
2009: Wisniewski Stephen R; Rush A John; Nierenberg Andrew A; Gaynes Bradley N; Warden Diane; Luther James F; McGrath Patrick J; Lavori Philip W; Thase Michael E; Fava Maurizio; Trivedi Madhukar H
Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.
The American journal of psychiatry 2009;166(5):599-607.
2009: Warden Diane; Rush A John; Wisniewski Stephen R; Lesser Ira M; Kornstein Susan G; Balasubramani G K; Thase Michael E; Preskorn Sheldon H; Nierenberg Andrew A; Young Elizabeth A; Shores-Wilson Kathy; Trivedi Madhukar H
What predicts attrition in second step medication treatments for depression?: a STAR*D Report.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009;12(4):459-73.
2009: Berman Robert M; Fava Maurizio; Thase Michael E; Trivedi Madhukar H; Swanink René; McQuade Robert D; Carson William H; Adson David; Taylor Leslie; Hazel James; Marcus Ronald N
Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
CNS spectrums 2009;14(4):197-206.
2009: Gruber June; Harvey Allison G; Wang Po W; Brooks John O; Thase Michael E; Sachs Gary S; Ketter Terence A
Sleep functioning in relation to mood, function, and quality of life at entry to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Journal of affective disorders 2009;114(1-3):41-9.
2009: Thase Michael E
Pharmacologic and therapeutic strategies in treatment-resistant depression. Augmentation strategies.
CNS spectrums 2009;14(3 Suppl 4):7-10.
2009: Thase Michael E; Kornstein Susan G; Germain Jean-Michel; Jiang Qin; Guico-Pabia Christine; Ninan Philip T
An integrated analysis of the efficacy of desvenlafaxine compared with placebo in patients with major depressive disorder.
CNS spectrums 2009;14(3):144-54.
2009: Trivedi Madhukar H; Thase Michael E; Osuntokun Olawale; Henley David B; Case Michael; Watson Susan B; Campbell Giedra M; Corya Sara A
An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
The Journal of clinical psychiatry 2009;70(3):387-96.
2009: Szegedi Armin; Jansen Wim T; van Willigenburg Arjen P P; van der Meulen Egbert; Stassen Hans H; Thase Michael E
Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients.
The Journal of clinical psychiatry 2009;70(3):344-53.
2009: Kocsis James H; Leon Andrew C; Markowitz John C; Manber Rachel; Arnow Bruce; Klein Daniel N; Thase Michael E
Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination.
The Journal of clinical psychiatry 2009;70(3):354-61.
2009: Goldberg Joseph F; Brooks John O; Kurita Keiko; Hoblyn Jennifer C; Ghaemi S Nassir; Perlis Roy H; Miklowitz David J; Ketter Terence A; Sachs Gary S; Thase Michael E
Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.
The Journal of clinical psychiatry 2009;70(2):155-62.
2009: Goldberg Joseph F; Perlis Roy H; Bowden Charles L; Thase Michael E; Miklowitz David J; Marangell Lauren B; Calabrese Joseph R; Nierenberg Andrew A; Sachs Gary S
Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD.
The American journal of psychiatry 2009;166(2):173-81.
2009: Kennedy Sidney H; Andersen Henning F; Thase Michael E
Escitalopram in the treatment of major depressive disorder: a meta-analysis.
Current medical research and opinion 2009;25(1):161-75.
2009: Fleurence Rachael; Williamson Rebecca; Jing Yonghua; Kim Edward; Tran Quynh-Van; Pikalov Andrei S; Thase Michael E
A systematic review of augmentation strategies for patients with major depressive disorder.
Psychopharmacology bulletin 2009;42(3):57-90.
2009: Rothschild Anthony J; Dunlop Boadie W; Dunner David L; Friedman Edward S; Gelenberg Alan; Holland Peter; Kocsis James H; Kornstein Susan G; Shelton Richard; Trivedi Madhukar H; Zajecka John M; Goldstein Corey; Thase Michael E; Pedersen Ron; Keller Martin B
Assessing Rates and Predictors of Tachyphylaxis During the Prevention of Recurrent Episodes of Depression With Venlafaxine ER for Two Years (PREVENT) Study.
Psychopharmacology bulletin 2009;42(3):5-20.
2009: Mallinger Alan G; Frank Ellen; Thase Michael E; Barwell Michelle M; Diazgranados Nancy; Luckenbaugh David A; Kupfer David J
Revisiting the effectiveness of standard antidepressants in bipolar disorder: are monoamine oxidase inhibitors superior?
Psychopharmacology bulletin 2009;42(2):64-74.
2009: Demitrack Mark A; Thase Michael E
Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data.
Psychopharmacology bulletin 2009;42(2):5-38.
2009: Warden Diane; Rush A John; Wisniewski Stephen R; Lesser Ira M; Thase Michael E; Balasubramani G K; Shores-Wilson Kathy; Nierenberg Andrew A; Trivedi Madhukar H
Income and attrition in the treatment of depression: a STAR*D report.
Depression and anxiety 2009;26(7):622-33.
2008: Mallinger Alan G; Thase Michael E; Haskett Roger; Buttenfield Joan; Luckenbaugh David A; Frank Ellen; Kupfer David J; Manji Husseini K
Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms.
Bipolar disorders 2008;10(8):856-66.
2008: Trivedi Madhukar H; Thase Michael E; Fava Maurizio; Nelson Craig J; Yang Huyuan; Qi Ying; Tran Quynh-Van; Pikalov Andrei; Carlson Berit X; Marcus Ronald N; Berman Robert M
Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
The Journal of clinical psychiatry 2008;69(12):1928-36.
2008: Thase Michael E
Do antidepressants really work? A clinicians' guide to evaluating the evidence.
Current psychiatry reports 2008;10(6):487-94.
2008: Thase Michael E
Prediction of outcome to a second trial of antidepressant medications following nonremission with citalopram therapy.
Current psychiatry reports 2008;10(6):449-51.
2008: Frank Ellen; Soreca Isabella; Swartz Holly A; Fagiolini Andrea M; Mallinger Alan G; Thase Michael E; Grochocinski Victoria J; Houck Patricia R; Kupfer David J
The role of interpersonal and social rhythm therapy in improving occupational functioning in patients with bipolar I disorder.
The American journal of psychiatry 2008;165(12):1559-65.
2008: El-Mallakh Rif S; Ghaemi S Nassir; Sagduyu Kemal; Thase Michael E; Wisniewski Stephen R; Nierenberg Andrew A; Zhang Hong Wei; Pardo Tamara A; Sachs Gary;
Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients.
Journal of affective disorders 2008;111(2-3):372-7.
2008: Owens Michael J; Krulewicz Stan; Simon Jeffrey S; Sheehan David V; Thase Michael E; Carpenter David J; Plott Susan J; Nemeroff Charles B
Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(13):3201-12.
2008: Thase Michael E
Maintenance therapy for bipolar disorder.
The Journal of clinical psychiatry 2008;69(11):e32.
2008: Jindal Ripu D; Vasko Raymond C; Jennings J Richard; Fasiczka Amy L; Thase Michael E; Reynolds Charles F
Heart rate variability in depressed elderly.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2008;16(11):861-6.
2008: Gelenberg Alan J; Thase Michael E; Meyer Roger E; Goodwin Frederick K; Katz Martin M; Kraemer Helena Chmura; Potter William Z; Shelton Richard C; Fava Maurizio; Khan Arif; Trivedi Madhukar H; Ninan Philip T; Mann John J; Bergeson Susan; Endicott Jean; Kocsis James H; Leon Andrew C; Manji Husseini K; Rosenbaum Jerrold F
The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies.
The Journal of clinical psychiatry 2008;69(10):1513-28.
2008: Kocsis James H; Gelenberg Alan J; Rothbaum Barbara; Klein Daniel N; Trivedi Madhukar H; Manber Rachel; Keller Martin B; Howland Robert; Thase Michael E
Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment.
Journal of affective disorders 2008;110(1-2):55-61.
2008: Gilmer William S; Gollan Jackie K; Wisniewski Stephen R; Howland Robert H; Trivedi Madhukar H; Miyahara Sachiko; Fleck Jenelle; Thase Michael E; Alpert Jonathan E; Nierenberg Andrew A; Warden Diane; Fava Maurizio; Rush A John
Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report.
The Journal of clinical psychiatry 2008;69(8):1246-56.
2008: Nelson J Craig; Thase Michael E; Khan Arif; Nelson J Craig
Are antidepressants effective? What's a clinician to think?
The Journal of clinical psychiatry 2008;69(6):1014-5.
2008: Mago Rajnish; Mahajan Rajeev; Thase Michael E
Medically serious adverse effects of newer antidepressants.
Current psychiatry reports 2008;10(3):249-57.
2008: Manber Rachel; Kraemer Helena C; Arnow Bruce A; Trivedi Madhukar H; Rush A John; Thase Michael E; Rothbaum Barbara O; Klein Daniel N; Kocsis James H; Gelenberg Alan J; Keller Martin E
Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone.
Journal of consulting and clinical psychology 2008;76(3):459-67.
2008: Thase Michael E; Haight Barbara R; Johnson Marty C; Hunt Thomas; Krishen Alok; Fleck Richard J; Modell Jack G
A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension.
Journal of clinical psychopharmacology 2008;28(3):302-7.
2008: Marangell Lauren B; Dennehy Ellen B; Wisniewski Stephen R; Bauer Mark S; Miyahara Sachiko; Allen Michael H; Martinez Melissa; Al Jurdi Rayan K; Thase Michael E
Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD.
The Journal of clinical psychiatry 2008;69(6):916-22.
2008: Weisler Richard H; Calabrese Joseph R; Thase Michael E; Arvekvist Robert; Stening Göran; Paulsson Björn; Suppes Trisha
Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies.
The Journal of clinical psychiatry 2008;69(5):769-82.
2008: Gaynes Bradley N; Rush A John; Trivedi Madhukar H; Wisniewski Stephen R; Balasubramani G K; McGrath Patrick J; Thase Michael E; Klinkman Michael; Nierenberg Andrew A; Yates William R; Fava Maurizio
Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D.
Journal of general internal medicine 2008;23(5):551-60.
2008: Bryan Charlene J; Songer Thomas J; Brooks Maria Mori; Thase Michael E; Gaynes Bradley N; Klinkman Michael; Rush A John; Trivedi Madhukar H; Fava Maurizio; Wisniewski Stephen R
A comparison of baseline sociodemographic and clinical characteristics between major depressive disorder patients with and without diabetes: a STAR*D report.
Journal of affective disorders 2008;108(1-2):113-20.
2008: Marcus Ronald N; McQuade Robert D; Carson William H; Hennicken Delphine; Fava Maurizio; Simon Jeffrey S; Trivedi Madhukar H; Thase Michael E; Berman Robert M
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Journal of clinical psychopharmacology 2008;28(2):156-65.
2008: Papakostas George I; Fava Maurizio; Thase Michael E
Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches.
Biological psychiatry 2008;63(7):699-704.
2008: Thase Michael E
Management of patients with treatment-resistant depression.
The Journal of clinical psychiatry 2008;69(3):e8.
2008: Avery David H; Isenberg Keith E; Sampson Shirlene M; Janicak Philip G; Lisanby Sarah H; Maixner Daniel F; Loo Colleen; Thase Michael E; Demitrack Mark A; George Mark S
Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial.
The Journal of clinical psychiatry 2008;69(3):441-51.
2008: Schneck Christopher D; Miklowitz David J; Miyahara Sachiko; Araga Mako; Wisniewski Stephen; Gyulai Laszlo; Allen Michael H; Thase Michael E; Sachs Gary S
The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD.
The American journal of psychiatry 2008;165(3):370-7; quiz 410.
2008: Thase Michael E
Quetiapine monotherapy for bipolar depression.
Neuropsychiatric disease and treatment 2008;4(1):11-21.
2008: Thase Michael E; Jonas Alan; Khan Arif; Bowden Charles L; Wu Xiaoling; McQuade Robert D; Carson William H; Marcus Ronald N; Owen Randall
Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
Journal of clinical psychopharmacology 2008;28(1):13-20.
2008: Nemeroff Charles B; Entsuah Richard; Benattia Isma; Demitrack Mark; Sloan Diane M; Thase Michael E
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
Biological psychiatry 2008;63(4):424-34.
2008: Perahia David G S; Pritchett Yili Lu; Kajdasz Daniel K; Bauer Michael; Jain Rakesh; Russell James M; Walker Daniel J; Spencer Kimberly A; Froud Debbie M; Raskin Joel; Thase Michael E
A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Journal of psychiatric research 2008;42(1):22-34.
2008: Thase Michael E
Selecting appropriate treatments for maintenance therapy for bipolar disorder.
The Journal of clinical psychiatry 2008;69 Suppl 5():28-35.
2008: Gyulai Laszlo; Bauer Mark S; Marangell Lauren B; Dennehy Ellen B; Thase Michael E; Otto Michael W; Zhang Hongwei; Wisniewski Stephen R; Miklowitz David J; Rapaport Mark H; Baldassano Claudia F; Sachs Gary S
Correlates of functioning in bipolar disorder.
Psychopharmacology bulletin 2008;41(4):51-64.
2008: Trivedi Madhukar H; Kocsis James H; Thase Michael E; Morris David W; Wisniewski Stephen R; Leon Andrew C; Gelenberg Alan J; Klein Daniel N; Niederehe George; Schatzberg Alan F; Ninan Philip T; Keller Martin B
REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy:Rationale and Design.
Psychopharmacology bulletin 2008;41(4):5-33.
2008: Thase Michael E
Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy.
Psychopharmacology bulletin 2008;41(2):58-85.
2008: Thase Michael E; Denko Timothey
Pharmacotherapy of mood disorders.
Annual review of clinical psychology 2008;4():53-91.
2007: Thase Michael E
Augmentation strategies for depression: history and concepts.
CNS spectrums 2007;12(12 Suppl 22):3-5.
2007: Thase Michael E
STEP-BD and bipolar depression: what have we learned?
Current psychiatry reports 2007;9(6):497-503.
2007: Thase Michael E
Treatment of refractory bipolar depression.
Current psychiatry reports 2007;9(6):495-6.
2007: Papakostas George I; Montgomery Stuart A; Thase Michael E; Katz Judith R; Krishen Alok; Tucker Vivian L
Comparing the rapidity of response during treatment of major depressive disorder with bupropion and the SSRIs: a pooled survival analysis of 7 double-blind, randomized clinical trials.
The Journal of clinical psychiatry 2007;68(12):1907-12.
2007: Thase Michael E
Molecules that mediate mood.
The New England journal of medicine 2007;357(23):2400-2.
2007: Thase Michael E; Pritchett Yili Lu; Ossanna Melissa J; Swindle Ralph W; Xu Jimmy; Detke Michael J
Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder.
Journal of clinical psychopharmacology 2007;27(6):672-6.
2007: Keller Martin B; Trivedi Madhukar H; Thase Michael E; Shelton Richard C; Kornstein Susan G; Nemeroff Charles B; Friedman Edward S; Gelenberg Alan J; Kocsis James H; Dunner David L; Dunlop Boadie W; Hirschfeld Robert M; Rothschild Anthony J; Ferguson James M; Schatzberg Alan F; Zajecka John M; Pedersen Ron; Yan Bing; Ahmed Saeeduddin; Schmidt Michael; Ninan Philip T
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
Biological psychiatry 2007;62(12):1371-9.
2007: Papakostas George I; Thase Michael E; Fava Maurizio; Nelson J Craig; Shelton Richard C
Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
Biological psychiatry 2007;62(11):1217-27.
2007: Brown Charlotte; Battista Deena R; Sereika Susan M; Bruehlman Richard D; Dunbar-Jacob Jacqueline; Thase Michael E
Primary care patients' personal illness models for depression: relationship to coping behavior and functional disability.
General hospital psychiatry 2007;29(6):492-500.
2007: Keck Paul E; Frye Mark A; Thase Michael E
Bipolar depression: best practices for the hospitalized patient.
CNS spectrums 2007;12(11 Suppl 19):1-13.
2007: Montgomery Stuart A; Baldwin David S; Blier Pierre; Fineberg Naomi A; Kasper Siegfried; Lader Malcolm; Lam Raymond W; Lépine Jean-Pierre; Möller Hans-Jürgen; Nutt David J; Rouillon Frederic; Schatzberg Alan F; Thase Michael E
Which antidepressants have demonstrated superior efficacy? A review of the evidence.
International clinical psychopharmacology 2007;22(6):323-9.
2007: Truman Christine J; Goldberg Joseph F; Ghaemi S Nassir; Baldassano Claudia F; Wisniewski Stephen R; Dennehy Ellen B; Thase Michael E; Sachs Gary S
Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
The Journal of clinical psychiatry 2007;68(10):1472-9.
2007: Drevets Wayne C; Thase Michael E; Moses-Kolko Eydie L; Price Julie; Frank Ellen; Kupfer David J; Mathis Chester
Serotonin-1A receptor imaging in recurrent depression: replication and literature review.
Nuclear medicine and biology 2007;34(7):865-77.
2007: Zisook Sidney; Lesser Ira; Stewart Jonathan W; Wisniewski Stephen R; Balasubramani G K; Fava Maurizio; Gilmer William S; Dresselhaus Timothy R; Thase Michael E; Nierenberg Andrew A; Trivedi Madhukar H; Rush A John
Effect of age at onset on the course of major depressive disorder.
The American journal of psychiatry 2007;164(10):1539-46.
2007: Dubé Sanjay; Tollefson Gary D; Thase Michael E; Briggs Susan D; Van Campen Luann E; Case Michael; Tohen Mauricio
Onset of antidepressant effect of olanzapine and olanzapine/fluoxetine combination in bipolar depression.
Bipolar disorders 2007;9(6):618-27.
2007: Goldberg Joseph F; Perlis Roy H; Ghaemi S Nassir; Calabrese Joseph R; Bowden Charles L; Wisniewski Stephen; Miklowitz David J; Sachs Gary S; Thase Michael E
Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.
The American journal of psychiatry 2007;164(9):1348-55.
2007: Miklowitz David J; Otto Michael W; Frank Ellen; Reilly-Harrington Noreen A; Kogan Jane N; Sachs Gary S; Thase Michael E; Calabrese Joseph R; Marangell Lauren B; Ostacher Michael J; Patel Jayendra; Thomas Marshall R; Araga Mako; Gonzalez Jodi M; Wisniewski Stephen R
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial.
The American journal of psychiatry 2007;164(9):1340-7.
2007: Keller Martin B; Trivedi Madhukar H; Thase Michael E; Shelton Richard C; Kornstein Susan G; Nemeroff Charles B; Friedman Edward S; Gelenberg Alan J; Kocsis James H; Dunner David L; Hirschfeld Robert M A; Rothschild Anthony J; Ferguson James M; Schatzberg Alan F; Zajecka John M; Pedersen Ronald D; Yan Bing; Ahmed Saeeduddin; Musgnung Jeff; Ninan Philip T
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
The Journal of clinical psychiatry 2007;68(8):1246-56.
2007: Fava Maurizio; Thase Michael E; DeBattista Charles; Doghramji Karl; Arora Sanjay; Hughes Rod J
Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2007;19(3):153-9.
2007: Kocsis James H; Thase Michael E; Trivedi Madhukar H; Shelton Richard C; Kornstein Susan G; Nemeroff Charles B; Friedman Edward S; Gelenberg Alan J; Dunner David L; Hirschfeld Robert M A; Rothschild Anthony J; Ferguson James M; Schatzberg Alan F; Zajecka John M; Pedersen Ronald D; Yan Bing; Ahmed Saeed; Musgnung Jeff; Ninan Philip T; Keller Martin B
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.
The Journal of clinical psychiatry 2007;68(7):1014-23.
2007: Moses-Kolko Eydie L; Price Julie C; Thase Michael E; Meltzer Carolyn Cidis; Kupfer David J; Mathis Chester A; Bogers Wendy D; Berman Susan R; Houck Patricia R; Schneider Trisha N; Drevets Wayne C
Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635.
Synapse (New York, N.Y.) 2007;61(7):523-30.
2007: Wisniewski Stephen R; Fava Maurizio; Trivedi Madhukar H; Thase Michael E; Warden Diane; Niederehe George; Friedman Edward S; Biggs Melanie M; Sackeim Harold A; Shores-Wilson Kathy; McGrath Patrick J; Lavori Philip W; Miyahara Sachiko; Rush A John
Acceptability of second-step treatments to depressed outpatients: a STAR*D report.
The American journal of psychiatry 2007;164(5):753-60.
2007: Thase Michael E; Friedman Edward S; Biggs Melanie M; Wisniewski Stephen R; Trivedi Madhukar H; Luther James F; Fava Maurizio; Nierenberg Andrew A; McGrath Patrick J; Warden Diane; Niederehe George; Hollon Steven D; Rush A John
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.
The American journal of psychiatry 2007;164(5):739-52.
2007: Brown Charlotte; Battista Deena R; Sereika Susan M; Bruehlman Richard D; Dunbar-Jacob Jacqueline; Thase Michael E
How can you improve antidepressant adherence?
The Journal of family practice 2007;56(5):356-63.
2007: Najavits Lisa M; Harned Melanie S; Gallop Robert J; Butler Stephen F; Barber Jacques P; Thase Michael E; Crits-Christoph Paul
Six-month treatment outcomes of cocaine-dependent patients with and without PTSD in a multisite national trial.
Journal of studies on alcohol and drugs 2007;68(3):353-61.
2007: Rapaport Mark Hyman; Thase Michael E
Translating the evidence on atypical depression into clinical practice.
The Journal of clinical psychiatry 2007;68(4):e11.
2007: Stewart Jonathan W; Thase Michael E
Treating DSM-IV depression with atypical features.
The Journal of clinical psychiatry 2007;68(4):e10.
2007: Miklowitz David J; Otto Michael W; Frank Ellen; Reilly-Harrington Noreen A; Wisniewski Stephen R; Kogan Jane N; Nierenberg Andrew A; Calabrese Joseph R; Marangell Lauren B; Gyulai Laszlo; Araga Mako; Gonzalez Jodi M; Shirley Edwin R; Thase Michael E; Sachs Gary S
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program.
Archives of general psychiatry 2007;64(4):419-26.
2007: Sachs Gary S; Nierenberg Andrew A; Calabrese Joseph R; Marangell Lauren B; Wisniewski Stephen R; Gyulai Laszlo; Friedman Edward S; Bowden Charles L; Fossey Mark D; Ostacher Michael J; Ketter Terence A; Patel Jayendra; Hauser Peter; Rapport Daniel; Martinez James M; Allen Michael H; Miklowitz David J; Otto Michael W; Dennehy Ellen B; Thase Michael E
Effectiveness of adjunctive antidepressant treatment for bipolar depression.
The New England journal of medicine 2007;356(17):1711-22.
2007: Nemeroff Charles B; Thase Michael E;
A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
Journal of psychiatric research 2007;41(3-4):351-9.
2007: Parker Gordon B; Thase Michael E
Atypical depression: a valid subtype?
The Journal of clinical psychiatry 2007;68(3):e08.
2007: Blier Pierre; Keller Martin B; Pollack Mark H; Thase Michael E; Zajecka John M; Dunner David L
Preventing recurrent depression: long-term treatment for major depressive disorder.
The Journal of clinical psychiatry 2007;68(3):e06.
2007: Thase Michael E
On the propriety of collaborations between academicians and the pharmaceutical industry: an alternate viewpoint.
World psychiatry : official journal of the World Psychiatric Association (WPA) 2007;6(1):29-31.
2007: Thase Michael E; Corya Sara A; Osuntokun Olawale; Case Michael; Henley David B; Sanger Todd M; Watson Susan B; Dubé Sanjay
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder.
The Journal of clinical psychiatry 2007;68(2):224-36.
2007: Davidson Jonathan R T; Thase Michael E
A history of the concept of atypical depression.
The Journal of clinical psychiatry 2007;68(2):e03.
2007: Gallop Robert J; Crits-Christoph Paul; Ten Have Thomas R; Barber Jacques P; Frank Arlene; Griffin Margaret L; Thase Michael E
Differential transitions between cocaine use and abstinence for men and women.
Journal of consulting and clinical psychology 2007;75(1):95-103.
2007: Kobak Kenneth A; Kane John M; Thase Michael E; Nierenberg Andrew A
Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms?
Journal of clinical psychopharmacology 2007;27(1):1-5.
2007: Siegle Greg J; Thompson Wesley; Carter Cameron S; Steinhauer Stuart R; Thase Michael E
Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features.
Biological psychiatry 2007;61(2):198-209.
2007: Arnow Bruce A; Blasey Christine; Manber Rachel; Constantino Michael J; Markowitz John C; Klein Daniel N; Thase Michael E; Kocsis James H; Rush A John
Dropouts versus completers among chronically depressed outpatients.
Journal of affective disorders 2007;97(1-3):197-202.
2007: Hirschfeld Robert Ma; Calabrese Joseph R; Frye Mark A; Lavori Philip W; Sachs Gary; Thase Michael E; Wagner Karen Dineen
Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening.
Psychopharmacology bulletin 2007;40(3):7-14.
2007: Thase Michael E
Recognition and diagnosis of atypical depression.
The Journal of clinical psychiatry 2007;68 Suppl 8():11-6.
2007: Andrews Gavin; Brugha Traolach; Thase Michael E; Duffy Farifteh Firoozmand; Rucci Paola; Slade Timothy
Dimensionality and the category of major depressive episode.
International journal of methods in psychiatric research 2007;16 Suppl 1():S41-51.
2007: Thase Michael E
Introduction: new directions in the treatment of atypical depression.
The Journal of clinical psychiatry 2007;68 Suppl 3():4-9.
2007: Grant M M; Friedman E S; Haskett R F; Riso L P; Thase M E
Urinary free cortisol levels among depressed men and women: differential relationships to age and symptom severity?
Archives of women's mental health 2007;10(2):73-8.
2007: Gonzalez Jodi M; Thompson Peter; Escamilla Michael; Araga Mako; Singh Vivek; Farrelly Niamh; Thase Michael E; Miklowitz David J; Bowden Charles L
Treatment characteristics and illness burden among European Americans, African Americans, and Latinos in the first 2,000 patients of the systematic treatment enhancement program for bipolar disorder.
Psychopharmacology bulletin 2007;40(1):31-46.
2006: Thase Michael E
New directions in the treatment of atypical depression.
The Journal of clinical psychiatry 2006;67(12):e18.
2006: Thase Michael E
The failure of evidence-based medicine to guide treatment of antidepressant nonresponders.
The Journal of clinical psychiatry 2006;67(12):1833-5.
2006: Thase Michael E
Preventing relapse and recurrence of depression: a brief review of therapeutic options.
CNS spectrums 2006;11(12 Suppl 15):12-21.
2006: Thase Michael E; Macfadden Wayne; Weisler Richard H; Chang William; Paulsson Björn; Khan Arifulla; Calabrese Joseph R;
Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
Journal of clinical psychopharmacology 2006;26(6):600-9.
2006: Thase Michael E
Pharmacotherapy of bipolar depression: an update.
Current psychiatry reports 2006;8(6):478-88.
2006: Thase Michael E
Head-to-head comparison of olanzapine/fluoxetine combination and lamotrigine in bipolar I depression.
Current psychiatry reports 2006;8(6):475-7.
2006: Rush A John; Trivedi Madhukar H; Wisniewski Stephen R; Nierenberg Andrew A; Stewart Jonathan W; Warden Diane; Niederehe George; Thase Michael E; Lavori Philip W; Lebowitz Barry D; McGrath Patrick J; Rosenbaum Jerrold F; Sackeim Harold A; Kupfer David J; Luther James; Fava Maurizio
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
The American journal of psychiatry 2006;163(11):1905-17.
2006: Marangell Lauren B; Bauer Mark S; Dennehy Ellen B; Wisniewski Stephen R; Allen Michael H; Miklowitz David J; Oquendo Maria A; Frank Ellen; Perlis Roy H; Martinez James M; Fagiolini Andrea; Otto Michael W; Chessick Cheryl A; Zboyan Holly A; Miyahara Sachiko; Sachs Gary; Thase Michael E
Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years.
Bipolar disorders 2006;8(5 Pt 2):566-75.
2006: Thase Michael E; Clayton Anita H; Haight Barbara R; Thompson April H; Modell Jack G; Johnston J Andrew
A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.
Journal of clinical psychopharmacology 2006;26(5):482-8.
2006: McGrath Patrick J; Stewart Jonathan W; Fava Maurizio; Trivedi Madhukar H; Wisniewski Stephen R; Nierenberg Andrew A; Thase Michael E; Davis Lori; Biggs Melanie M; Shores-Wilson Kathy; Luther James F; Niederehe George; Warden Diane; Rush A John
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
The American journal of psychiatry 2006;163(9):1531-41; quiz 1666.
2006: Nierenberg Andrew A; Fava Maurizio; Trivedi Madhukar H; Wisniewski Stephen R; Thase Michael E; McGrath Patrick J; Alpert Jonathan E; Warden Diane; Luther James F; Niederehe George; Lebowitz Barry; Shores-Wilson Kathy; Rush A John
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.
The American journal of psychiatry 2006;163(9):1519-30; quiz 1665.
2006: Rush A John; Kraemer Helena C; Sackeim Harold A; Fava Maurizio; Trivedi Madhukar H; Frank Ellen; Ninan Philip T; Thase Michael E; Gelenberg Alan J; Kupfer David J; Regier Darrel A; Rosenbaum Jerrold F; Ray Oakley; Schatzberg Alan F;
Report by the ACNP Task Force on response and remission in major depressive disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(9):1841-53.
2006: Fava Maurizio; Rush A John; Wisniewski Stephen R; Nierenberg Andrew A; Alpert Jonathan E; McGrath Patrick J; Thase Michael E; Warden Diane; Biggs Melanie; Luther James F; Niederehe George; Ritz Louise; Trivedi Madhukar H
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
The American journal of psychiatry 2006;163(7):1161-72.
2006: Thase Michael E; Shelton Richard C; Khan Arifulla
Treatment with venlafaxine extended release after SSRI nonresponse or intolerance: a randomized comparison of standard- and higher-dosing strategies.
Journal of clinical psychopharmacology 2006;26(3):250-8.
2006: Friedman E; Gyulai L; Bhargava M; Landen M; Wisniewski S; Foris J; Ostacher M; Medina R; Thase M
Seasonal changes in clinical status in bipolar disorder: a prospective study in 1000 STEP-BD patients.
Acta psychiatrica Scandinavica 2006;113(6):510-7.
2006: Ghaemi S Nassir; Hsu Douglas J; Thase Michael E; Wisniewski Stephen R; Nierenberg Andrew A; Miyahara Sachiko; Sachs Gary
Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants.
Psychiatric services (Washington, D.C.) 2006;57(5):660-5.
2006: Zhang Hongwei; Wisniewski Stephen R; Bauer Mark S; Sachs Gary S; Thase Michael E;
Comparisons of perceived quality of life across clinical states in bipolar disorder: data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants.
Comprehensive psychiatry 2006;47(3):161-8.
2006: Thase Michael E
Novel transdermal delivery formulation of the monoamine oxidase inhibitor selegiline nearing release for treatment of depression.
The Journal of clinical psychiatry 2006;67(4):671-2.
2006: Siegle Greg J; Carter Cameron S; Thase Michael E
Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy.
The American journal of psychiatry 2006;163(4):735-8.
2006: Pollack Mark H; Simon Naomi M; Fagiolini Andrea; Pitman Roger; McNally Richard J; Nierenberg Andrew A; Miyahara Sachicko; Sachs Gary S; Perlman Carol; Ghaemi S Nassir; Thase Michael E; Otto Michael W
Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder.
The Journal of clinical psychiatry 2006;67(3):394-9.
2006: Fossey Mark D; Otto Michael W; Yates William R; Wisniewski Steve R; Gyulai Laszlo; Allen Michael H; Miklowitz David J; Coon Kim A; Ostacher Michael J; Neel Jackie L; Thase Michael E; Sachs Gary S; Weiss Roger D;
Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2006;15(2):138-43.
2006: Trivedi Madhukar H; Fava Maurizio; Wisniewski Stephen R; Thase Michael E; Quitkin Frederick; Warden Diane; Ritz Louise; Nierenberg Andrew A; Lebowitz Barry D; Biggs Melanie M; Luther James F; Shores-Wilson Kathy; Rush A John;
Medication augmentation after the failure of SSRIs for depression.
The New England journal of medicine 2006;354(12):1243-52.
2006: Rush A John; Trivedi Madhukar H; Wisniewski Stephen R; Stewart Jonathan W; Nierenberg Andrew A; Thase Michael E; Ritz Louise; Biggs Melanie M; Warden Diane; Luther James F; Shores-Wilson Kathy; Niederehe George; Fava Maurizio;
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
The New England journal of medicine 2006;354(12):1231-42.
2006: Thase Michael E
Treatment of anxiety disorders with venlafaxine XR.
Expert review of neurotherapeutics 2006;6(3):269-82.
2006: Thase Michael E
Managing depressive and anxiety disorders with escitalopram.
Expert opinion on pharmacotherapy 2006;7(4):429-40.
2006: Joffe Hadine; Kim Deborah R; Foris John M; Baldassano Claudia F; Gyulai Laszlo; Hwang Cindy H; McLaughlin Wren L; Sachs Gary S; Thase Michael E; Harlow Bernard L; Cohen Lee S
Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy controls.
The Journal of clinical psychiatry 2006;67(2):297-304.
2006: Gelenberg Alan J; Kocsis James H; McCullough James P; Ninan Philip T; Thase Michael E
The state of knowledge of chronic depression.
The Journal of clinical psychiatry 2006;67(2):179-84.
2006: Thase Michael E; Fava Maurizio; DeBattista Charles; Arora Sanjay; Hughes Rod J
Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study.
CNS spectrums 2006;11(2):93-102.
2006: Perlis Roy H; Ostacher Michael J; Patel Jayendra K; Marangell Lauren B; Zhang Hongwei; Wisniewski Stephen R; Ketter Terence A; Miklowitz David J; Otto Michael W; Gyulai Laszlo; Reilly-Harrington Noreen A; Nierenberg Andrew A; Sachs Gary S; Thase Michael E
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
The American journal of psychiatry 2006;163(2):217-24.
2006: Nierenberg Andrew A; Ostacher Michael J; Calabrese Joseph R; Ketter Terence A; Marangell Lauren B; Miklowitz David J; Miyahara Sachiko; Bauer Mark S; Thase Michael E; Wisniewski Stephen R; Sachs Gary S
Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
The American journal of psychiatry 2006;163(2):210-6.
2006: Bauer Mark S; Wisniewski Stephen R; Marangell Lauren B; Chessick Cheryl A; Allen Michael H; Dennehy Ellen B; Miklowitz David J; Thase Michael E; Sachs Gary S
Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
The Journal of clinical psychiatry 2006;67(1):48-55.
2006: Landén Mikael; Thase Michael E
A model to explain the therapeutic effects of serotonin reuptake inhibitors: the role of 5-HT2 receptors.
Psychopharmacology bulletin 2006;39(1):147-66.
2006: Bauer Mark S; Wisniewski Stephen R; Kogan Jane N; Marangell Lauren B; Thase Michael E; Sachs Gary
Brief report: paroxetine in younger and adult individuals at high risk for suicide.
Psychopharmacology bulletin 2006;39(1):31-7.
2006: Thase Michael E
Bipolar depression: diagnostic and treatment considerations.
Development and psychopathology 2006;18(4):1213-30.
2006: Thase Michael E
Depression and sleep: pathophysiology and treatment.
Dialogues in clinical neuroscience 2006;8(2):217-26.
2005: Bowden Charles L; Ketter Terence A; Sachs Gary S; Thase Michael E
Focus on bipolar disorder treatment.
The Journal of clinical psychiatry 2005;66(12):1598-609.
2005: Martinez James M; Marangell Lauren B; Simon Naomi M; Miyahara Sachiko; Wisniewski Stephen R; Harrington Jennifer; Pollack Mark H; Sachs Gary S; Thase Michael E
Baseline predictors of serious adverse events at one year among patients with bipolar disorder in STEP-BD.
Psychiatric services (Washington, D.C.) 2005;56(12):1541-8.
2005: Goldberg Joseph F; Allen Michael H; Miklowitz David A; Bowden Charles L; Endick Carrie J; Chessick Cheryl A; Wisniewski Stephen R; Miyahara Sachiko; Sagduyu Kemal; Thase Michael E; Calabrese Joseph R; Sachs Gary S
Suicidal ideation and pharmacotherapy among STEP-BD patients.
Psychiatric services (Washington, D.C.) 2005;56(12):1534-40.
2005: Brown Charlotte; Battista Deena R; Bruehlman Richard; Sereika Susan S; Thase Michael E; Dunbar-Jacob Jacqueline
Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence.
Medical care 2005;43(12):1203-7.
2005: Thase Michael E
Bipolar depression: issues in diagnosis and treatment.
Harvard review of psychiatry 2005;13(5):257-71.
2005: Thase Michael E; Entsuah Richard; Cantillon Marc; Kornstein Susan G
Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions.
Journal of women's health (2002) 2005;14(7):609-16.
2005: Frank Ellen; Kupfer David J; Thase Michael E; Mallinger Alan G; Swartz Holly A; Fagiolini Andrea M; Grochocinski Victoria; Houck Patricia; Scott John; Thompson Wesley; Monk Timothy
Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder.
Archives of general psychiatry 2005;62(9):996-1004.
2005: Manber Rachel; Blasey Christine; Arnow Bruce; Markowitz John C; Thase Michael E; Rush A John; Dowling Frank; Koscis James; Trivedi Madhukar; Keller Martin B
Assessing insomnia severity in depression: comparison of depression rating scales and sleep diaries.
Journal of psychiatric research 2005;39(5):481-8.
2005: Thase Michael E; Haight Barbara R; Richard Nathalie; Rockett Carol B; Mitton Melinda; Modell Jack G; VanMeter Susan; Harriett April E; Wang Younghua
Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials.
The Journal of clinical psychiatry 2005;66(8):974-81.
2005: Parker G B; Malhi G S; Crawford J G; Thase M E
Identifying "paradigm failures" contributing to treatment-resistant depression.
Journal of affective disorders 2005;87(2-3):185-91.
2005: Weiss Roger D; Ostacher Michael J; Otto Michael W; Calabrese Joseph R; Fossey Mark; Wisniewski Stephen R; Bowden Charles L; Nierenberg Andrew A; Pollack Mark H; Salloum Ihsan M; Simon Naomi M; Thase Michael E; Sachs Gary S;
Does recovery from substance use disorder matter in patients with bipolar disorder?
The Journal of clinical psychiatry 2005;66(6):730-5; quiz 808-9.
2005: Schatzberg Alan F; Rush A John; Arnow Bruce A; Banks Phillip L C; Blalock Janice A; Borian Frances E; Howland Robert; Klein Daniel N; Kocsis James H; Kornstein Susan G; Manber Rachel; Markowitz John C; Miller Ivan; Ninan Philip T; Rothbaum Barbara O; Thase Michael E; Trivedi Madhukar H; Keller Martin B
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
Archives of general psychiatry 2005;62(5):513-20.
2005: Hollon Steven D; Jarrett Robin B; Nierenberg Andrew A; Thase Michael E; Trivedi Madhukar; Rush A John
Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?
The Journal of clinical psychiatry 2005;66(4):455-68.
2005: Thase Michael E; Tran Pierre V; Wiltse Curtis; Pangallo Beth A; Mallinckrodt Craig; Detke Michael J
Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine.
Journal of clinical psychopharmacology 2005;25(2):132-40.
2005: Thase Michael E
Correlates and consequences of chronic insomnia.
General hospital psychiatry 2005;27(2):100-12.
2005: Lieberman Jeffery A; Greenhouse Joel; Hamer Robert M; Krishnan K Ranga; Nemeroff Charles B; Sheehan David V; Thase Michael E; Keller Martin B
Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(3):445-60.
2005: Weiss Roger D; Griffin Margaret L; Gallop Robert J; Najavits Lisa M; Frank Arlene; Crits-Christoph Paul; Thase Michael E; Blaine Jack; Gastfriend David R; Daley Dennis; Luborsky Lester
The effect of 12-step self-help group attendance and participation on drug use outcomes among cocaine-dependent patients.
Drug and alcohol dependence 2005;77(2):177-84.
2005: Rush A John; Trivedi Madhukar H; Carmody Thomas J; Ibrahim Hisham M; Markowitz John C; Keitner Gabor I; Kornstein Susan G; Arnow Bruce; Klein Daniel N; Manber Rachel; Dunner David L; Gelenberg Alan J; Kocsis James H; Nemeroff Charles B; Fawcett Jan; Thase Michael E; Russell James M; Jody Darlene N; Borian Frances E; Keller Martin B
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(2):405-16.
2005: Landén Mikael; Högberg Per; Thase Michael E
Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.
The Journal of clinical psychiatry 2005;66(1):100-6.
2005: Fava Maurizio; Thase Michael E; DeBattista Charles
A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.
The Journal of clinical psychiatry 2005;66(1):85-93.
2005: Salloum Ihsan M; Cornelius Jack R; Daley Dennis C; Kirisci Levent; Himmelhoch Jonathan M; Thase Michael E
Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Archives of general psychiatry 2005;62(1):37-45.
2005: Mansour Hader A; Talkowski Michael E; Wood Joel; Pless Lora; Bamne Mikhil; Chowdari Kodavali V; Allen Michael; Bowden Charles L; Calabrese Joseph; El-Mallakh Rif S; Fagiolini Andrea; Faraone Stephen V; Fossey Mark D; Friedman Edward S; Gyulai Laszlo; Hauser Peter; Ketter Terence A; Loftis Jennifer M; Marangell Lauren B; Miklowitz David J; Nierenberg Andrew A; Patel Jayendra; Sachs Gary S; Sklar Pamela; Smoller Jordan W; Thase Michael E; Frank Ellen; Kupfer David J; Nimgaonkar Vishwajit L
Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter.
Annals of medicine 2005;37(8):590-602.
2005: Mansour Hader A; Wood Joel; Chowdari Kodvali V; Dayal Madhulika; Thase Michael E; Kupfer David J; Monk Timothy H; Devlin Bernie; Nimgaonkar Vishwajit L
Circadian phase variation in bipolar I disorder.
Chronobiology international 2005;22(3):571-84.
2005: Fava Maurizio; Rush A John; Thase Michael E; Clayton Anita; Stahl Stephen M; Pradko James F; Johnston J Andrew
15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL.
Primary care companion to the Journal of clinical psychiatry 2005;7(3):106-13.
2004: Simon Naomi M; Otto Michael W; Wisniewski Stephen R; Fossey Mark; Sagduyu Kemal; Frank Ellen; Sachs Gary S; Nierenberg Andrew A; Thase Michael E; Pollack Mark H
Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
The American journal of psychiatry 2004;161(12):2222-9.
2004: Kogan Jane N; Otto Michael W; Bauer Mark S; Dennehy Ellen B; Miklowitz David J; Zhang Hong-Wei; Ketter Terence; Rudorfer Matthew V; Wisniewski Stephen R; Thase Michael E; Calabrese Joseph; Sachs Gary S;
Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Bipolar disorders 2004;6(6):460-9.
2004: Thase Michael E
Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence.
CNS spectrums 2004;9(11):808-16, 818-21.
2004: Khan Arif; Kolts Russell L; Thase Michael E; Krishnan K Ranga Rama; Brown Walter
Research design features and patient characteristics associated with the outcome of antidepressant clinical trials.
The American journal of psychiatry 2004;161(11):2045-9.
2004: Judd Lewis L; Rapaport Mark Hyman; Yonkers Kimberly A; Rush A John; Frank Ellen; Thase Michael E; Kupfer David J; Plewes John M; Schettler Pamela J; Tollefson Gary
Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder.
The American journal of psychiatry 2004;161(10):1864-71.
2004: Simon Naomi M; Otto Michael W; Weiss Roger D; Bauer Mark S; Miyahara Sachiko; Wisniewski Stephen R; Thase Michael E; Kogan Jane; Frank Ellen; Nierenberg Andrew A; Calabrese Joseph R; Sachs Gary S; Pollack Mark H;
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
Journal of clinical psychopharmacology 2004;24(5):512-20.
2004: Siqueland Lynne; Crits-Christoph Paul; Barber Jacques P; Connolly Gibbons Mary Beth; Gallop Robert; Griffin Margaret; Frank Arlene; Thase Michael E; Luborsky Lester; Liese Bruce
What aspects of treatment matter to the patient in the treatment of cocaine dependence?
Journal of substance abuse treatment 2004;27(2):169-78.
2004: Gelenberg Alan J; Shelton Richard C; Crits-Christoph Paul; Keller Martin B; Dunner David L; Hirschfeld Robert M A; Thase Michael E; Russell James M; Lydiard R Bruce; Gallop Robert J; Todd Linda; Hellerstein David J; Goodnick Paul J; Keitner Gabor I; Stahl Stephen M; Halbreich Uriel; Hopkins Heather S
The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.
The Journal of clinical psychiatry 2004;65(8):1114-9.
2004: Klein Daniel N; Santiago Neil J; Vivian Dina; Blalock Janice A; Kocsis James H; Markowitz John C; McCullough Jr James P; Rush A John; Trivedi Madhukar H; Arnow Bruce A; Dunner David L; Manber Rachel; Rothbaum Barbara; Thase Michael E; Keitner Gabor I; Miller Ivan W; Keller Martin B
Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression.
Journal of consulting and clinical psychology 2004;72(4):681-8.
2004: Hill S Kristian; Keshavan Matcheri S; Thase Michael E; Sweeney John A
Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression.
The American journal of psychiatry 2004;161(6):996-1003.
2004: Nierenberg Andrew A; Quitkin Frederic M; Kremer Charlotte; Keller Martin B; Thase Michael E
Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(5):1012-8.
2004: Swartz Holly A; Frank Ellen; Shear M Katherine; Thase Michael E; Fleming M A Dana; Scott John
A pilot study of brief interpersonal psychotherapy for depression among women.
Psychiatric services (Washington, D.C.) 2004;55(4):448-50.
2004: Marangell Lauren B; Martinez James M; Ketter Terence A; Bowden Charles L; Goldberg Joseph F; Calabrese Joseph R; Miyahara Sachiko; Miklowitz David J; Sachs Gary S; Thase Michael E;
Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD.
Bipolar disorders 2004;6(2):139-43.
2004: Lembke Anna; Miklowitz David J; Otto Michael W; Zhang Hongwei; Wisniewski Stephen R; Sachs Gary S; Thase Michael E; Ketter Terence A;
Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program.
Journal of psychiatric practice 2004;10(2):81-7.
2004: Siegle Greg J; Steinhauer Stuart R; Thase Michael E
Pupillary assessment and computational modeling of the Stroop task in depression.
International journal of psychophysiology : official journal of the International Organization of Psychophysiology 2004;52(1):63-76.
2004: Jindal Ripu D; Thase Michael E
Treatment of insomnia associated with clinical depression.
Sleep medicine reviews 2004;8(1):19-30.
2004: Rush A John; Fava Maurizio; Wisniewski Stephen R; Lavori Philip W; Trivedi Madhukar H; Sackeim Harold A; Thase Michael E; Nierenberg Andrew A; Quitkin Frederic M; Kashner T Michael; Kupfer David J; Rosenbaum Jerrold F; Alpert Jonathan; Stewart Jonathan W; McGrath Patrick J; Biggs Melanie M; Shores-Wilson Kathy; Lebowitz Barry D; Ritz Louise; Niederehe George;
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
Controlled clinical trials 2004;25(1):119-42.
2004: Jindal Ripu D; Buysse Daniel J; Thase Michael E
Maintenance treatment of insomnia: what can we learn from the depression literature?
The American journal of psychiatry 2004;161(1):19-24.
2004: Thase Michael E
Introduction: the dual-action debate: does pharmacology matter?
The Journal of clinical psychiatry 2004;65 Suppl 17():3-4.
2003: Jindal Ripu D; Friedman Edward S; Berman Susan R; Fasiczka Amy L; Howland Robert H; Thase Michael E
Effects of sertraline on sleep architecture in patients with depression.
Journal of clinical psychopharmacology 2003;23(6):540-8.
2003: Arnow Bruce A; Manber Rachel; Blasey Christine; Klein Daniel N; Blalock Janice A; Markowitz John C; Rothbaum Barbara O; Rush A John; Thase Michael E; Riso Lawrence P; Vivian Dina; McCullough James P; Keller Martin B
Therapeutic reactance as a predictor of outcome in the treatment of chronic depression.
Journal of consulting and clinical psychology 2003;71(6):1025-35.
2003: Klein Daniel N; Schwartz Joseph E; Santiago Neil J; Vivian Dina; Vocisano Carina; Castonguay Louis G; Arnow Bruce; Blalock Janice A; Manber Rachel; Markowitz John C; Riso Lawrence P; Rothbaum Barbara; McCullough James P; Thase Michael E; Borian Frances E; Miller Ivan W; Keller Martin B
Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics.
Journal of consulting and clinical psychology 2003;71(6):997-1006.
2003: Nemeroff Charles B; Heim Christine M; Thase Michael E; Klein Daniel N; Rush A John; Schatzberg Alan F; Ninan Philip T; McCullough James P; Weiss Paul M; Dunner David L; Rothbaum Barbara O; Kornstein Susan; Keitner Gabor; Keller Martin B
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(24):14293-6.
2003: Segal Zindel V; Pearson Jane L; Thase Michael E
Challenges in preventing relapse in major depression. Report of a National Institute of Mental Health Workshop on state of the science of relapse prevention in major depression.
Journal of affective disorders 2003;77(2):97-108.
2003: Jindal Ripu D; Thase Michael E
Integrating psychotherapy and pharmacotherapy to improve outcomes among patients with mood disorders.
Psychiatric services (Washington, D.C.) 2003;54(11):1484-90.
2003: Gelenberg Alan J; Trivedi Madhukar H; Rush A John; Thase Michael E; Howland Robert; Klein Daniel N; Kornstein Susan G; Dunner David L; Markowitz John C; Hirschfeld Robert M A; Keitner Gabor I; Zajecka John; Kocsis James H; Russell James M; Miller Ivan; Manber Rachel; Arnow Bruce; Rothbaum Barbara; Munsaka Melvin; Banks Phillip; Borian Frances E; Keller Martin B
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
Biological psychiatry 2003;54(8):806-17.
2003: Crits-Christoph Paul; Gibbons Mary Beth Connolly; Barber Jacques P; Gallop Robert; Beck Aaron T; Mercer Delinda; Tu Xin; Thase Michael E; Weiss Roger D; Frank Arlene
Mediators of outcome of psychosocial treatments for cocaine dependence.
Journal of consulting and clinical psychology 2003;71(5):918-25.
2003: Najavits Lisa M; Runkel Ragna; Neuner Christina; Frank Arlene F; Thase Michael E; Crits-Christoph Paul; Blaine Jack
Rates and symptoms of PTSD among cocaine-dependent patients.
Journal of studies on alcohol 2003;64(5):601-6.
2003: Rush A John; Trivedi Madhukar H; Ibrahim Hicham M; Carmody Thomas J; Arnow Bruce; Klein Daniel N; Markowitz John C; Ninan Philip T; Kornstein Susan; Manber Rachel; Thase Michael E; Kocsis James H; Keller Martin B
The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.
Biological psychiatry 2003;54(5):573-83.
2003: Sachs Gary S; Thase Michael E; Otto Michael W; Bauer Mark; Miklowitz David; Wisniewski Stephen R; Lavori Philip; Lebowitz Barry; Rudorfer Mathew; Frank Ellen; Nierenberg Andrew A; Fava Maurizio; Bowden Charles; Ketter Terence; Marangell Lauren; Calabrese Joseph; Kupfer David; Rosenbaum Jerrold F
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).
Biological psychiatry 2003;53(11):1028-42.
2003: Thase Michael E; Bhargava Manoj; Sachs Gary S
Treatment of bipolar depression: current status, continued challenges, and the STEP-BD approach.
The Psychiatric clinics of North America 2003;26(2):495-518.
2003: Fava Maurizio; Rush A John; Trivedi Madhukar H; Nierenberg Andrew A; Thase Michael E; Sackeim Harold A; Quitkin Frederic M; Wisniewski Steven; Lavori Philip W; Rosenbaum Jerrold F; Kupfer David J
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.
The Psychiatric clinics of North America 2003;26(2):457-94, x.
2003: Manber R; Arnow B; Blasey C; Vivian D; McCullough J P; Blalock J A; Klein D N; Markowitz J C; Riso L P; Rothbaum B; Rush A J; Thase M E; Keller M B
Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication.
Psychological medicine 2003;33(4):693-702.
2003: Calabrese Joseph R; Londborg Peter D; Shelton Melvin D; Thase Michael E
Citalopram treatment of fluoxetine-intolerant depressed patients.
The Journal of clinical psychiatry 2003;64(5):562-7.
2003: Healy David; Thase Michael E
Is academic psychiatry for sale?
The British journal of psychiatry : the journal of mental science 2003;182():388-90.
2003: Siegle Greg J; Konecky Roma O; Thase Michael E; Carter Cameron S
Relationships between amygdala volume and activity during emotional information processing tasks in depressed and never-depressed individuals: an fMRI investigation.
Annals of the New York Academy of Sciences 2003;985():481-4.
2003: Rush A John; Thase Michael E; Dubé Sanjay
Research issues in the study of difficult-to-treat depression.
Biological psychiatry 2003;53(8):743-53.
2003: Manber Rachel; Rush A John; Thase Michael E; Amow Bruce; Klein Dan; Trivedi Madhukar H; Korenstein Susan G; Markowitz John C; Dunner David L; Munsaka Melvin; Borian Fran E; Martin; Keller B
The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression.
Sleep 2003;26(2):130-6.
2003: Thase Michael E
Achieving remission and managing relapse in depression.
The Journal of clinical psychiatry 2003;64 Suppl 18():3-7.
2003: Thase Michael E
Treatment of recurrent depression: an alternate viewpoint.
CNS drugs 2003;17(15):1119-22.
2003: Jindal Ripu D; Fasiczka Amy L; Himmelhoch Jonathan M; Mallinger Alan G; Thase Michael E
Effects of tranylcypromine on the sleep of patients with anergic bipolar depression.
Psychopharmacology bulletin 2003;37(3):118-26.
2003: Thase Michael E
Evaluating antidepressant therapies: remission as the optimal outcome.
The Journal of clinical psychiatry 2003;64 Suppl 13():18-25.
2003: Thase Michael E
New approaches to managing difficult-to-treat depressions.
The Journal of clinical psychiatry 2003;64 Suppl 1():3-4.
2003: Thase Michael E
Effectiveness of antidepressants: comparative remission rates.
The Journal of clinical psychiatry 2003;64 Suppl 2():3-7.
2002: Frank Ellen; Cyranowski Jill M; Rucci Paola; Shear M Katherine; Fagiolini Andrea; Thase Michael E; Cassano Giovanni B; Grochocinski Victoria J; Kostelnik Bryan; Kupfer David J
Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder.
Archives of general psychiatry 2002;59(10):905-11.
2002: Kim Yookyung; Pilkonis Paul A; Frank Ellen; Thase Michael E; Reynolds Charles F
Differential functioning of the Beck depression inventory in late-life patients: use of item response theory.
Psychology and aging 2002;17(3):379-91.
2002: Zajecka John; Dunner David L; Gelenberg Alan J; Hirschfeld Robert M A; Kornstein Susan G; Ninan Philip T; Rush A John; Thase Michael E; Trivedi Madhukar H; Arnow Bruce A; Borian Frances E; Manber Rachel; Keller Martin B
Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination.
The Journal of clinical psychiatry 2002;63(8):709-16.
2002: Montgomery Stuart A; Bech Per; Blier Pierre; Möller Hans-Jürgen; Nierenberg Andrew A; Pinder Roger M; Quitkin Frederic M; Reimitz Paul-Egbert; Rosenbaum Jerrold F; Rush A John; Stassen H H; Thase Michael E
Selecting methodologies for the evaluation of differences in time to response between antidepressants.
The Journal of clinical psychiatry 2002;63(8):694-9.
2002: Riso Lawrence P; Miyatake Ronald K; Thase Michael E
The search for determinants of chronic depression: a review of six factors.
Journal of affective disorders 2002;70(2):103-15.
2002: Rucci Paola; Frank Ellen; Kostelnik Bryan; Fagiolini Andrea; Mallinger Alan G; Swartz Holly A; Thase Michael E; Siegel Lori; Wilson Dorothy; Kupfer David J
Suicide attempts in patients with bipolar I disorder during acute and maintenance phases of intensive treatment with pharmacotherapy and adjunctive psychotherapy.
The American journal of psychiatry 2002;159(7):1160-4.
2002: Thase Michael E; Rush A John; Manber Rachel; Kornstein Susan G; Klein Daniel N; Markowitz John C; Ninan Philip T; Friedman Edward S; Dunner David L; Schatzberg Alan F; Borian Frances E; Trivedi Madhukar H; Keller Martin B
Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.
The Journal of clinical psychiatry 2002;63(6):493-500.
2002: Ninan Philip T; Rush A John; Crits-Christoph Paul; Kornstein Susan G; Manber Rachel; Thase Michael E; Trivedi Madhukar H; Rothbaum Barbara O; Zajecka John; Borian Frances E; Keller Martin B
Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
The Journal of clinical psychiatry 2002;63(5):434-41.
2002: Siegle Greg J; Steinhauer Stuart R; Thase Michael E; Stenger V Andrew; Carter Cameron S
Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals.
Biological psychiatry 2002;51(9):693-707.
2002: Rapaport Mark Hyman; Judd Lewis L; Schettler Pamela J; Yonkers Kimberly Ann; Thase Michael E; Kupfer David J; Frank Ellen; Plewes John M; Tollefson Gary D; Rush A John
A descriptive analysis of minor depression.
The American journal of psychiatry 2002;159(4):637-43.
2002: Klein Donald F; Thase Michael E; Endicott Jean; Adler Lawrence; Glick Ira; Kalali Amir; Leventer Steven; Mattes Jeffrey; Ross Peter; Bystritsky Alexander
Improving clinical trials: American Society of Clinical Psychopharmacology recommendations.
Archives of general psychiatry 2002;59(3):272-8.
2002: Thase Michael E; Rush A John; Howland Robert H; Kornstein Susan G; Kocsis James H; Gelenberg Alan J; Schatzberg Alan F; Koran Lorrin M; Keller Martin B; Russell James M; Hirschfeld Robert M A; LaVange Lisa M; Klein Daniel N; Fawcett Jan; Harrison Wilma
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression.
Archives of general psychiatry 2002;59(3):233-9.
2002: Thase Michael E
What role do atypical antipsychotic drugs have in treatment-resistant depression?
The Journal of clinical psychiatry 2002;63(2):95-103.
2002: Jindal Ripu D; Thase Michael E; Fasiczka Amy L; Friedman Edward S; Buysse Daniel J; Frank Ellen; Kupfer David J
Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: II. Comparison during remission.
Biological psychiatry 2002;51(3):230-6.
2002: Hirschfeld Robert M A; Dunner David L; Keitner Gabor; Klein Daniel N; Koran Lorrin M; Kornstein Susan G; Markowitz John C; Miller Ivan; Nemeroff Charles B; Ninan Philip T; Rush A John; Schatzberg Alan F; Thase Michael E; Trivedi Madhukar H; Borian Frances E; Crits-Christoph Paul; Keller Martin B
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination.
Biological psychiatry 2002;51(2):123-33.
2002: Cole Daniel P; Thase Michael E; Mallinger Alan G; Soares Jair C; Luther James F; Kupfer David J; Frank Ellen
Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function.
The American journal of psychiatry 2002;159(1):116-21.
2002: Thase Michael E
Studying new antidepressants: if there were a light at the end of the tunnel, could we see it?
The Journal of clinical psychiatry 2002;63 Suppl 2():24-8.
2002: Kornstein Susan G; Sloan Diane M E; Thase Michael E
Gender-specific differences in depression and treatment response.
Psychopharmacology bulletin 2002;36(4 Suppl 3):99-112.
2002: Thase Michael E; Sloan Diane M E; Kornstein Susan G
Remission as the critical outcome of depression treatment.
Psychopharmacology bulletin 2002;36(4 Suppl 3):12-25.
2002: Kornstein Susan G; Sloan Diane M E; Thase Michael E
Gender-specific differences in depression and treatment response.
Psychopharmacology bulletin 2002;36(4):99-112.
2002: Thase Michael E; Sloan Diane M E; Kornstein Susan G
Remission as the critical outcome of depression treatment.
Psychopharmacology bulletin 2002;36(4):12-25.
2002: Thase Michael E
The next step forward: a move toward evidence, and away from fear of the industry.
Psychopharmacology bulletin 2002;36(4):4-5.
2002: Thase Michael E; Trivedi Madhukar
Optimizing treatment outcomes for patients with depression and generalized anxiety disorder.
Psychopharmacology bulletin 2002;36 Suppl 2():93-102.
2002: Thase Michael E; Ninan Philip T
New goals in the treatment of depression: moving toward recovery.
Psychopharmacology bulletin 2002;36 Suppl 2():24-35.
2002: Thase Michael E; Ferguson James M; Lydiard R Bruce; Wilcox Charles S
Citalopram treatment of paroxetine-intolerant depressed patients.
Depression and anxiety 2002;16(3):128-33.
2002: Thase Michael E
Comparing the methods used to compare antidepressants.
Psychopharmacology bulletin 2002;36 Suppl 1():Suppl 1-17; quiz Suppl 18-9.
2002: Siqueland Lynne; Crits-Christoph Paul; Gallop Robert; Barber Jacques P; Griffin Margaret L; Thase Michael E; Daley Denis; Frank Arlene; Gastfriend David R; Blaine Jack; Connolly Mary Beth; Gladis Madeline
Retention in psychosocial treatment of cocaine dependence: predictors and impact on outcome.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2002;11(1):24-40.
2001: Lavori P W; Rush A J; Wisniewski S R; Alpert J; Fava M; Kupfer D J; Nierenberg A; Quitkin F M; Sackeim H A; Thase M E; Trivedi M
Strengthening clinical effectiveness trials: equipoise-stratified randomization.
Biological psychiatry 2001;50(10):792-801.
2001: Thase M E; Nierenberg A A; Keller M B; Panagides J;
Efficacy of mirtazapine for prevention of depressive relapse: a placebo-controlled double-blind trial of recently remitted high-risk patients.
The Journal of clinical psychiatry 2001;62(10):782-8.
2001: Crits-Christoph P; Siqueland L; McCalmont E; Weiss R D; Gastfriend D R; Frank A; Moras K; Barber J P; Blaine J; Thase M E
Impact of psychosocial treatments on associated problems of cocaine-dependent patients.
Journal of consulting and clinical psychology 2001;69(5):825-30.
2001: Thase M E; Feighner J P; Lydiard R B
Citalopram treatment of fluoxetine nonresponders.
The Journal of clinical psychiatry 2001;62(9):683-7.
2001: Thase M E
Neuroimaging profiles and the differential therapies of depression.
Archives of general psychiatry 2001;58(7):651-3.
2001: Koran L M; Gelenberg A J; Kornstein S G; Howland R H; Friedman R A; DeBattista C; Klein D; Kocsis J H; Schatzberg A F; Thase M E; Rush A J; Hirschfeld R M; LaVange L M; Keller M B
Sertraline versus imipramine to prevent relapse in chronic depression.
Journal of affective disorders 2001;65(1):27-36.
2001: Brown C; Dunbar-Jacob J; Palenchar D R; Kelleher K J; Bruehlman R D; Sereika S; Thase M E
Primary care patients' personal illness models for depression: a preliminary investigation.
Family practice 2001;18(3):314-20.
2001: Shelton R C; Keller M B; Gelenberg A; Dunner D L; Hirschfeld R; Thase M E; Russell J; Lydiard R B; Crits-Cristoph P; Gallop R; Todd L; Hellerstein D; Goodnick P; Keitner G; Stahl S M; Halbreich U
Effectiveness of St John's wort in major depression: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2001;285(15):1978-86.
2001: Nofzinger E A; Berman S; Fasiczka A; Miewald J M; Meltzer C C; Price J C; Sembrat R C; Wood A; Thase M E
Effects of bupropion SR on anterior paralimbic function during waking and REM sleep in depression: preliminary findings using.
Psychiatry research 2001;106(2):95-111.
2001: Sackeim H A; Haskett R F; Mulsant B H; Thase M E; Mann J J; Pettinati H M; Greenberg R M; Crowe R R; Cooper T B; Prudic J
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2001;285(10):1299-307.
2001: Thase M E; Entsuah A R; Rudolph R L
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.
The British journal of psychiatry : the journal of mental science 2001;178():234-41.
2001: Barber J P; Luborsky L; Gallop R; Crits-Christoph P; Frank A; Weiss R D; Thase M E; Connolly M B; Gladis M; Foltz C; Siqueland L
Therapeutic alliance as a predictor of outcome and retention in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study.
Journal of consulting and clinical psychology 2001;69(1):119-24.
2001: Taylor R; Mallinger A G; Frank E; Rucci P; Thase M E; Kupfer D J
Variability of erythrocyte and serum lithium levels correlates with therapist treatment adherence efforts and maintenance treatment outcome.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(2):192-7.
2001: Thase M E; Salloum I M; Cornelius J D
Comorbid alcoholism and depression: treatment issues.
The Journal of clinical psychiatry 2001;62 Suppl 20():32-41.
2001: Thase M E; Friedman E S; Howland R H
Management of treatment-resistant depression: psychotherapeutic perspectives.
The Journal of clinical psychiatry 2001;62 Suppl 18():18-24.
2001: Thase M E
Methodology to measure onset of action.
The Journal of clinical psychiatry 2001;62 Suppl 15():18-21.
2000: Chengappa K N; Tohen M; Levine J; Jacobs T; Thase M E; Sanger T M; Kupfer D J
Response to placebo among bipolar I disorder patients experiencing their first manic episode.
Bipolar disorders 2000;2(4):332-5.
2000: Nofzinger E A; Fasiczka A; Berman S; Thase M E
Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder.
The Journal of clinical psychiatry 2000;61(11):858-62.
2000: Kornstein S G; Schatzberg A F; Thase M E; Yonkers K A; McCullough J P; Keitner G I; Gelenberg A J; Ryan C E; Hess A L; Harrison W; Davis S M; Keller M B
Gender differences in chronic major and double depression.
Journal of affective disorders 2000;60(1):1-11.
2000: Salloum I M; Thase M E
Impact of substance abuse on the course and treatment of bipolar disorder.
Bipolar disorders 2000;2(3 Pt 2):269-80.
2000: Sachs G S; Thase M E
Bipolar disorder therapeutics: maintenance treatment.
Biological psychiatry 2000;48(6):573-81.
2000: Thase M E; Sachs G S
Bipolar depression: pharmacotherapy and related therapeutic strategies.
Biological psychiatry 2000;48(6):558-72.
2000: Kornstein S G; Schatzberg A F; Thase M E; Yonkers K A; McCullough J P; Keitner G I; Gelenberg A J; Davis S M; Harrison W M; Keller M B
Gender differences in treatment response to sertraline versus imipramine in chronic depression.
The American journal of psychiatry 2000;157(9):1445-52.
2000: McCullough J P; Klein D N; Keller M B; Holzer C E; Davis S M; Kornstein S G; Howland R H; Thase M E; Harrison W M
Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): validity of the distinction.
Journal of abnormal psychology 2000;109(3):419-27.
2000: Thase M E; Friedman E S; Fasiczka A L; Berman S R; Frank E; Nofzinger E A; Reynolds C F
Treatment of men with major depression: a comparison of sequential cohorts treated with either cognitive-behavioral therapy or newer generation antidepressants.
The Journal of clinical psychiatry 2000;61(7):466-72.
2000: Keller M B; McCullough J P; Klein D N; Arnow B; Dunner D L; Gelenberg A J; Markowitz J C; Nemeroff C B; Russell J M; Thase M E; Trivedi M H; Zajecka J
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.
The New England journal of medicine 2000;342(20):1462-70.
2000: Cornelius J R; Salloum I M; Haskett R F; Daley D C; Cornelius M D; Thase M E; Perel J M
Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study.
Addictive behaviors 2000;25(2):307-10.
2000: Thase M E; Friedman E S; Berman S R; Fasiczka A L; Lis J A; Howland R H; Simons A D
Is cognitive behavior therapy just a 'nonspecific' intervention for depression? A retrospective comparison of consecutive cohorts treated with cognitive behavior therapy or supportive counseling and pill placebo.
Journal of affective disorders 2000;57(1-3):63-71.
2000: Thase M E; Friedman E S; Howland R H
Venlafaxine and treatment-resistant depression.
Depression and anxiety 2000;12 Suppl 1():55-62.
2000: Thase M E
Treatment issues related to sleep and depression.
The Journal of clinical psychiatry 2000;61 Suppl 11():46-50.
2000: Siqueland L; Crits-Christoph P; Barber J P; Butler S F; Thase M; Najavits L; Onken L S
The role of therapist characteristics in training effects in cognitive, supportive-expressive, and drug counseling therapies for cocaine dependence.
The Journal of psychotherapy practice and research 2000;9(3):123-30.
2000: Thase M E
Treatment of severe depression.
The Journal of clinical psychiatry 2000;61 Suppl 1():17-25.
1999: Tew J D; Mulsant B H; Haskett R F; Prudic J; Thase M E; Crowe R R; Dolata D; Begley A E; Reynolds C F; Sackeim H A
Acute efficacy of ECT in the treatment of major depression in the old-old.
The American journal of psychiatry 1999;156(12):1865-70.
1999: Frank E; Swartz H A; Mallinger A G; Thase M E; Weaver E V; Kupfer D J
Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality.
Journal of abnormal psychology 1999;108(4):579-87.
1999: Klein D N; Schatzberg A F; McCullough J P; Dowling F; Goodman D; Howland R H; Markowitz J C; Smith C; Thase M E; Rush A J; LaVange L; Harrison W M; Keller M B
Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response.
Journal of affective disorders 1999;55(2-3):149-57.
1999: Mammen O K; Shear M K; Pilkonis P A; Kolko D J; Thase M E; Greeno C G
Anger attacks: correlates and significance of an underrecognized symptom.
The Journal of clinical psychiatry 1999;60(9):633-42; quiz 643.
1999: Sweeney J A; Luna B; Haas G L; Keshavan M S; Mann J J; Thase M E
Pursuit tracking impairments in schizophrenia and mood disorders: step-ramp studies with unmedicated patients.
Biological psychiatry 1999;46(5):671-80.
1999: Thase M E
Psychotherapy of depression: current status, future directions.
CNS spectrums 1999;4(7):62-6.
1999: Thase M E; Friedman E S
Is psychotherapy an effective treatment for melancholia and other severe depressive states?
Journal of affective disorders 1999;54(1-2):1-19.
1999: Crits-Christoph P; Siqueland L; Blaine J; Frank A; Luborsky L; Onken L S; Muenz L R; Thase M E; Weiss R D; Gastfriend D R; Woody G E; Barber J P; Butler S F; Daley D; Salloum I; Bishop S; Najavits L M; Lis J; Mercer D; Griffin M L; Moras K; Beck A T
Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study.
Archives of general psychiatry 1999;56(6):493-502.
1999: Merriam E P; Thase M E; Haas G L; Keshavan M S; Sweeney J A
Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting Test performance.
The American journal of psychiatry 1999;156(5):780-2.
1999: Cluss P A; Marcus S C; Kelleher K J; Thase M E; Arvay L A; Kupfer D J
Diagnostic certainty of a voluntary bipolar disorder case registry.
Journal of affective disorders 1999;52(1-3):93-9.
1999: Cornelius J R; Salloum I M; Haskett R F; Ehler J G; Jarrett P J; Thase M E; Perel J M
Fluoxetine versus placebo for the marijuana use of depressed alcoholics.
Addictive behaviors 1999;24(1):111-4.
1999: Thase M E
Summary: defining remission in patients treated with antidepressants.
The Journal of clinical psychiatry 1999;60 Suppl 22():35-6.
1999: Thase M E
Introduction: defining remission in patients treated with antidepressants.
The Journal of clinical psychiatry 1999;60 Suppl 22():3-6.
1999: Hamilton S; Mellman L A; Gabbard G O; Thase M E; Markowitz J C
Psychotherapies in residency training.
The Journal of psychotherapy practice and research 1999;8(4):302-13.
1999: Thase M E
Antidepressant treatment of the depressed patient with insomnia.
The Journal of clinical psychiatry 1999;60 Suppl 17():28-31; discussion 46-8.
1999: Thase M E
Long-term nature of depression.
The Journal of clinical psychiatry 1999;60 Suppl 14():3-9; discussion 31-5.
1999: Siqueland L; Horn A; Moras K; Woody G; Weiss R; Blaine J; Bishop S; Barber J; Thase M
Cocaine-induced mood disorder: prevalence rates and psychiatric symptoms in an outpatient cocaine-dependent sample.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 1999;8(2):165-9.
1999: Thase M E
Redefining antidepressant efficacy toward long-term recovery.
The Journal of clinical psychiatry 1999;60 Suppl 6():15-9.
1999: Thase M E
How should efficacy be evaluated in randomized clinical trials of treatments for depression?
The Journal of clinical psychiatry 1999;60 Suppl 4():23-31; discussion 32.
1999: Frank E; Thase M E
Natural history and preventative treatment of recurrent mood disorders.
Annual review of medicine 1999;50():453-68.
1998: Hirschfeld R M; Russell J M; Delgado P L; Fawcett J; Friedman R A; Harrison W M; Koran L M; Miller I W; Thase M E; Howland R H; Connolly M A; Miceli R J
Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.
The Journal of clinical psychiatry 1998;59(12):669-75.
1998: Miller I W; Keitner G I; Schatzberg A F; Klein D N; Thase M E; Rush A J; Markowitz J C; Schlager D S; Kornstein S G; Davis S M; Harrison W M; Keller M B
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.
The Journal of clinical psychiatry 1998;59(11):608-19.
1998: Keller M B; Gelenberg A J; Hirschfeld R M; Rush A J; Thase M E; Kocsis J H; Markowitz J C; Fawcett J A; Koran L M; Klein D N; Russell J M; Kornstein S G; McCullough J P; Davis S M; Harrison W M
The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
The Journal of clinical psychiatry 1998;59(11):598-607.
1998: Rush A J; Koran L M; Keller M B; Markowitz J C; Harrison W M; Miceli R J; Fawcett J A; Gelenberg A J; Hirschfeld R M; Klein D N; Kocsis J H; McCullough J P; Schatzberg A F; Thase M E
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.
The Journal of clinical psychiatry 1998;59(11):589-97.
1998: Keller M B; Kocsis J H; Thase M E; Gelenberg A J; Rush A J; Koran L; Schatzberg A; Russell J; Hirschfeld R; Klein D; McCullough J P; Fawcett J A; Kornstein S; LaVange L; Harrison W
Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial.
JAMA : the journal of the American Medical Association 1998;280(19):1665-72.
1998: Thase M E
Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients.
The Journal of clinical psychiatry 1998;59(10):502-8.
1998: Crits-Christoph P; Siqueland L; Chittams J; Barber J P; Beck A T; Frank A; Liese B; Luborsky L; Mark D; Mercer D; Onken L S; Najavits L M; Thase M E; Woody G
Training in cognitive, supportive-expressive, and drug counseling therapies for cocaine dependence.
Journal of consulting and clinical psychology 1998;66(3):484-92.
1998: Sweeney J A; Strojwas M H; Mann J J; Thase M E
Prefrontal and cerebellar abnormalities in major depression: evidence from oculomotor studies.
Biological psychiatry 1998;43(8):584-94.
1998: Thase M E; Fasiczka A L; Berman S R; Simons A D; Reynolds C F
Electroencephalographic sleep profiles before and after cognitive behavior therapy of depression.
Archives of general psychiatry 1998;55(2):138-44.
1998: Najavits L M; Gastfriend D R; Barber J P; Reif S; Muenz L R; Blaine J; Frank A; Crits-Christoph P; Thase M; Weiss R D
Cocaine dependence with and without PTSD among subjects in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study.
The American journal of psychiatry 1998;155(2):214-9.
1998: Najavits L M; Weiss R D; Reif S; Gastfriend D R; Siqueland L; Barber J P; Butler S F; Thase M; Blaine J
The Addiction Severity Index as a screen for trauma and posttraumatic stress disorder.
Journal of studies on alcohol 1998;59(1):56-62.
1998: Cornelius J R; Thase M E; Salloum I M; Cornelius M D; Black A; Mann J J
Cocaine use associated with increased suicidal behavior in depressed alcoholics.
Addictive behaviors 1998;23(1):119-21.
1998: Thase M E; Howland R H; Friedman E S
Treating antidepressant nonresponders with augmentation strategies: an overview.
The Journal of clinical psychiatry 1998;59 Suppl 5():5-12; discussion 13-5.
1998: Cornelius J R; Salloum I M; Thase M E; Haskett R F; Daley D C; Jones-Barlock A; Upsher C; Perel J M
Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
Psychopharmacology bulletin 1998;34(1):117-21.
1998: Salloum I M; Cornelius J R; Thase M E; Daley D C; Kirisci L; Spotts C
Naltrexone utility in depressed alcoholics.
Psychopharmacology bulletin 1998;34(1):111-5.
1998: Thase M E
Depression, sleep, and antidepressants.
The Journal of clinical psychiatry 1998;59 Suppl 4():55-65.
1997: Thase M E; Greenhouse J B; Frank E; Reynolds C F; Pilkonis P A; Hurley K; Grochocinski V; Kupfer D J
Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations.
Archives of general psychiatry 1997;54(11):1009-15.
1997: Thase M E
Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group.
The Journal of clinical psychiatry 1997;58(9):393-8.
1997: Crits-Christoph P; Siqueland L; Blaine J; Frank A; Luborsky L; Onken L S; Muenz L; Thase M E; Weiss R D; Gastfriend D R; Woody G; Barber J P; Butler S F; Daley D; Bishop S; Najavits L M; Lis J; Mercer D; Griffin M L; Moras K; Beck A T
The National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Rationale and methods.
Archives of general psychiatry 1997;54(8):721-6.
1997: Cornelius J R; Salloum I M; Ehler J G; Jarrett P J; Cornelius M D; Perel J M; Thase M E; Black A
Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial.
Archives of general psychiatry 1997;54(8):700-5.
1997: Thase M E; Kupfer D J; Fasiczka A J; Buysse D J; Simons A D; Frank E
Identifying an abnormal electroencephalographic sleep profile to characterize major depressive disorder.
Biological psychiatry 1997;41(9):964-73.
1997: Mallinger A G; Frank E; Thase M E; Dippold C S; Kupfer D J
Low rate of membrane lithium transport during treatment correlates with outcome of maintenance pharmacotherapy in bipolar disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;16(5):325-32.
1997: Riso L P; Thase M E; Howland R H; Friedman E S; Simons A D; Tu X M
A prospective test of criteria for response, remission, relapse, recovery, and recurrence in depressed patients treated with cognitive behavior therapy.
Journal of affective disorders 1997;43(2):131-42.
1997: Mulsant B H; Haskett R F; Prudic J; Thase M E; Malone K M; Mann J J; Pettinati H M; Sackeim H A
Low use of neuroleptic drugs in the treatment of psychotic major depression.
The American journal of psychiatry 1997;154(4):559-61.
1997: Thase M E; Buysse D J; Frank E; Cherry C R; Cornes C L; Mallinger A G; Kupfer D J
Which depressed patients will respond to interpersonal psychotherapy? The role of abnormal EEG sleep profiles.
The American journal of psychiatry 1997;154(4):502-9.
1997: Shelton R C; Davidson J; Yonkers K A; Koran L; Thase M E; Pearlstein T; Halbreich U
The undertreatment of dysthymia.
The Journal of clinical psychiatry 1997;58(2):59-65.
1997: Thase M E; Blomgren S L; Birkett M A; Apter J T; Tepner R G
Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.
The Journal of clinical psychiatry 1997;58(1):16-21.
1997: Thase M E; Rush A J
When at first you don't succeed: sequential strategies for antidepressant nonresponders.
The Journal of clinical psychiatry 1997;58 Suppl 13():23-9.
1997: Rush A J; Thase M E
Strategies and tactics in the treatment of chronic depression.
The Journal of clinical psychiatry 1997;58 Suppl 13():14-22.
1997: Thase M E
Psychotherapy of refractory depressions.
Depression and anxiety 1997;5(4):190-201.
1997: Thase M E
Integrating psychotherapy and pharmacotherapy for treatment of major depressive disorder. Current status and future considerations.
The Journal of psychotherapy practice and research 1997;6(4):300-6.
1997: Hlastala S A; Frank E; Mallinger A G; Thase M E; Ritenour A M; Kupfer D J
Bipolar depression: an underestimated treatment challenge.
Depression and anxiety 1997;5(2):73-83.
1997: Cornelius J R; Salloum I M; Ehler J G; Jarrett P J; Cornelius M D; Black A; Perel J M; Thase M E
Double-blind fluoxetine in depressed alcoholic smokers.
Psychopharmacology bulletin 1997;33(1):165-70.
1997: Najavits L M; Gastfriend D R; Nakayama E Y; Barber J P; Blaine J; Frank A; Muenz L R; Thase M
A measure of readiness for substance abuse treatment. Psychometric properties of the RAATE-R interview.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 1997;6(1):74-82.
1996: Cornelius J R; Salloum I M; Day N L; Thase M E; Mann J J
Patterns of suicidality and alcohol use in alcoholics with major depression.
Alcoholism, clinical and experimental research 1996;20(8):1451-5.
1996: Reynolds C F; Frank E; Kupfer D J; Thase M E; Perel J M; Mazumdar S; Houck P R
Treatment outcome in recurrent major depression: a post hoc comparison of elderly ("young old") and midlife patients.
The American journal of psychiatry 1996;153(10):1288-92.
1996: Thase M E; Fava M; Halbreich U; Kocsis J H; Koran L; Davidson J; Rosenbaum J; Harrison W
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
Archives of general psychiatry 1996;53(9):777-84.
1996: Thase M E; Kupfer D J
Recent developments in the pharmacotherapy of mood disorders.
Journal of consulting and clinical psychology 1996;64(4):646-59.
1996: Salloum I M; Daley D C; Cornelius J R; Kirisci L; Thase M E
Disproportionate lethality in psychiatric patients with concurrent alcohol and cocaine abuse.
The American journal of psychiatry 1996;153(7):953-5.
1996: Thase M E; Dubé S; Bowler K; Howland R H; Myers J E; Friedman E; Jarrett D B
Hypothalamic-pituitary-adrenocortical activity and response to cognitive behavior therapy in unmedicated, hospitalized depressed patients.
The American journal of psychiatry 1996;153(7):886-91.
1996: Thase M E
The role of Axis II comorbidity in the management of patients with treatment-resistant depression.
The Psychiatric clinics of North America 1996;19(2):287-309.
1996: Thase M E
Antidepressant options: venlafaxine in perspective.
Journal of clinical psychopharmacology 1996;16(3 Suppl 2):10S-18S; discussion 18S-20S.
1996: Cornelius J R; Fabrega H; Cornelius M D; Mezzich J; Maher P J; Salloum I M; Thase M E; Ulrich R F
Racial effects on the clinical presentation of alcoholics at a psychiatric hospital.
Comprehensive psychiatry 1996;37(2):102-8.
1996: Thase M E; Simons A D; Reynolds C F
Abnormal electroencephalographic sleep profiles in major depression: association with response to cognitive behavior therapy.
Archives of general psychiatry 1996;53(2):99-108.
1995: Cornelius J R; Jarrett P J; Thase M E; Fabrega H; Haas G L; Jones-Barlock A; Mezzich J E; Ulrich R F
Gender effects on the clinical presentation of alcoholics at a psychiatric hospital.
Comprehensive psychiatry 1995;36(6):435-40.
1995: Thase M E; Kupfer D J; Buysse D J; Frank E; Simons A D; McEachran A B; Rashid K F; Grochocinski V J
Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: I. Comparison during acute depressive states.
Biological psychiatry 1995;38(8):506-15.
1995: Thase M E; Trivedi M H; Rush A J
MAOIs in the contemporary treatment of depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1995;12(3):185-219.
1995: Cornelius J R; Salloum I M; Mezzich J; Cornelius M D; Fabrega H; Ehler J G; Ulrich R F; Thase M E; Mann J J
Disproportionate suicidality in patients with comorbid major depression and alcoholism.
The American journal of psychiatry 1995;152(3):358-64.
1995: Nofzinger E A; Reynolds C F; Thase M E; Frank E; Jennings J R; Fasiczka A L; Sullivan L R; Kupfer D J
REM sleep enhancement by bupropion in depressed men.
The American journal of psychiatry 1995;152(2):274-6.
1995: Salloum I M; Cornelius J R; Daley D C; Thase M E
The utility of diazepam loading in the treatment of alcohol withdrawal among psychiatric inpatients.
Psychopharmacology bulletin 1995;31(2):305-10.
1994: Thase M E; Reynolds C F; Frank E; Jennings J R; Nofzinger E; Fasiczka A L; Garamoni G; Kupfer D J
Polysomnographic studies of unmedicated depressed men before and after cognitive behavioral therapy.
The American journal of psychiatry 1994;151(11):1615-22.
1994: Cornelius J R; Fabrega H; Mezzich J; Ulrich R F; Thase M E
Characterizing organic mood syndrome, manic type.
Comprehensive psychiatry 1994;35(5):354-60.
1994: Johnson S L; Monroe S; Simons A; Thase M E
Clinical characteristics associated with interpersonal depression: symptoms, course and treatment response.
Journal of affective disorders 1994;31(2):97-109.
1994: Thase M E; Reynolds C F; Frank E; Simons A D; McGeary J; Fasiczka A L; Garamoni G G; Jennings J R; Kupfer D J
Do depressed men and women respond similarly to cognitive behavior therapy?
The American journal of psychiatry 1994;151(4):500-5.
1994: Nofzinger E A; Schwartz R M; Reynolds C F; Thase M E; Jennings J R; Frank E; Fasiczka A L; Garamoni G L; Kupfer D J
Affect intensity and phasic REM sleep in depressed men before and after treatment with cognitive-behavioral therapy.
Journal of consulting and clinical psychology 1994;62(1):83-91.
1993: Myers J E; Buysse D J; Thase M E; Perel J; Miewald J M; Cooper T B; Kupfer D J; Mann J J
The effects of fenfluramine on sleep and prolactin in depressed inpatients: a comparison of potential indices of brain serotonergic responsivity.
Biological psychiatry 1993;34(11):753-8.
1993: Nofzinger E A; Schwartz R M; Reynolds C F; Thase M E; Jennings J R; Frank E; Fasiczka A L; Garamoni G L; Kupfer D J
Correlation of nocturnal penile tumescence and daytime affect intensity in depressed men.
Psychiatry research 1993;49(2):139-50.
1993: Howland R H; Thase M E
A comprehensive review of cyclothymic disorder.
The Journal of nervous and mental disease 1993;181(8):485-93.
1993: Frank E; Kupfer D J; Perel J M; Cornes C; Mallinger A G; Thase M E; McEachran A B; Grochocinski V J
Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression.
Journal of affective disorders 1993;27(3):139-45.
1993: Nofzinger E A; Fasiczka A L; Thase M E; Reynolds C F; Frank E; Jennings J R; Garamoni G L; Matzzie J V; Kupfer D J
Are buckling force measurements reliable in nocturnal penile tumescence studies?
Sleep 1993;16(2):156-62.
1993: Nofzinger E A; Thase M E; Reynolds C F; Frank E; Jennings J R; Garamoni G L; Fasiczka A L; Kupfer D J
Sexual function in depressed men. Assessment by self-report, behavioral, and nocturnal penile tumescence measures before and after treatment with cognitive behavior therapy.
Archives of general psychiatry 1993;50(1):24-30.
1993: Thase M E; Simons A D; Reynolds C F
Psychobiological correlates of poor response to cognitive behavior therapy: potential indications for antidepressant pharmacotherapy.
Psychopharmacology bulletin 1993;29(2):293-301.
1993: Cornelius J R; Salloum I M; Cornelius M D; Perel J M; Thase M E; Ehler J G; Mann J J
Fluoxetine trial in suicidal depressed alcoholics.
Psychopharmacology bulletin 1993;29(2):195-9.
1993: Malone K M; Thase M E; Mieczkowski T; Myers J E; Stull S D; Cooper T B; Mann J J
Fenfluramine challenge test as a predictor of outcome in major depression.
Psychopharmacology bulletin 1993;29(2):155-61.
1992: Kupfer D J; Frank E; Perel J M; Cornes C; Mallinger A G; Thase M E; McEachran A B; Grochocinski V J
Five-year outcome for maintenance therapies in recurrent depression.
Archives of general psychiatry 1992;49(10):769-73.
1992: Thase M E
Long-term treatments of recurrent depressive disorders.
The Journal of clinical psychiatry 1992;53 Suppl():32-44.
1992: Thase M E; Simons A D; McGeary J; Cahalane J F; Hughes C; Harden T; Friedman E
Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment.
The American journal of psychiatry 1992;149(8):1046-52.
1992: Thase M E; Reynolds C F; Jennings J R; Frank E; Garamoni G L; Nofzinger E A; Fascizka A L; Kupfer D J
Diminished nocturnal penile tumescence in depression: a replication study.
Biological psychiatry 1992;31(11):1136-42.
1992: Garamoni G L; Reynolds C F; Thase M E; Frank E; Fasiczka A L
Shifts in affective balance during cognitive therapy of major depression.
Journal of consulting and clinical psychology 1992;60(2):260-6.
1992: Stuart S; Simons A D; Thase M E; Pilkonis P
Are personality assessments valid in acute major depression?
Journal of affective disorders 1992;24(4):281-9.
1992: Thase M E; Mallinger A G; McKnight D; Himmelhoch J M
Treatment of imipramine-resistant recurrent depression, IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression.
The American journal of psychiatry 1992;149(2):195-8.
1992: Thase M E; Frank E; Mallinger A G; Hamer T; Kupfer D J
Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors.
The Journal of clinical psychiatry 1992;53(1):5-11.
1992: Thase M E; Reynolds C F; Frank E; Jennings J R; Garamoni G L; Yeager A L; Kupfer D J
Early return to REM sleep after nocturnal awakening in depression.
Biological psychiatry 1992;31(2):171-6.
1992: Nofzinger E A; Reynolds C F; Jennings J R; Thase M E; Frank E; Yeager A; Kupfer D J
Results of nocturnal penile tumescence studies are abnormal in sexually functional diabetic men.
Archives of internal medicine 1992;152(1):114-8.
1992: Thase M E; Simons A D
Cognitive behavior therapy and relapse of nonbipolar depression: parallels with pharmacotherapy.
Psychopharmacology bulletin 1992;28(2):117-22.
1992: Frank E; Perel J M; Mallinger A G; Thase M E; Kupfer D J
Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depression.
Psychopharmacology bulletin 1992;28(3):231-5.
1991: Garamoni G L; Reynolds C F; Thase M E; Frank E; Berman S R; Fasiczka A L
The balance of positive and negative affects in major depression: a further test of the States of Mind model.
Psychiatry research 1991;39(2):99-108.
1991: Nofzinger E A; Thase M E; Reynolds C F; Himmelhoch J M; Mallinger A; Houck P; Kupfer D J
Hypersomnia in bipolar depression: a comparison with narcolepsy using the multiple sleep latency test.
The American journal of psychiatry 1991;148(9):1177-81.
1991: Howland R H; Thase M E
Biological studies of dysthymia.
Biological psychiatry 1991;30(3):283-304.
1991: Himmelhoch J M; Thase M E; Mallinger A G; Houck P
Tranylcypromine versus imipramine in anergic bipolar depression.
The American journal of psychiatry 1991;148(7):910-6.
1991: Thase M E; Simons A D; Cahalane J; McGeary J; Harden T
Severity of depression and response to cognitive behavior therapy.
The American journal of psychiatry 1991;148(6):784-9.
1991: Thase M E; Carpenter L; Kupfer D J; Frank E
Clinical significance of reversed vegetative subtypes of recurrent major depression.
Psychopharmacology bulletin 1991;27(1):17-22.
1990: Frank E; Kupfer D J; Perel J M; Cornes C; Jarrett D B; Mallinger A G; Thase M E; McEachran A B; Grochocinski V J
Three-year outcomes for maintenance therapies in recurrent depression.
Archives of general psychiatry 1990;47(12):1093-9.
1990: Reynolds C F; Kupfer D J; Thase M E; Frank E; Jarrett D B; Coble P A; Hoch C C; Buysse D J; Simons A D; Houck P R
Sleep, gender, and depression: an analysis of gender effects on the electroencephalographic sleep of 302 depressed outpatients.
Biological psychiatry 1990;28(8):673-84.
1990: Mallinger A G; Himmelhoch J M; Thase M E; Edwards D J; Knopf S
Plasma tranylcypromine: relationship to pharmacokinetic variables and clinical antidepressant actions.
Journal of clinical psychopharmacology 1990;10(3):176-83.
1990: Mallinger A G; Himmelhoch J M; Thase M E; Dippold C; Knopf S
Reduced cell membrane affinity for lithium ion during maintenance treatment of bipolar affective disorder.
Biological psychiatry 1990;27(7):795-8.
1989: Thase M E; Kupfer D J; Frank E; Jarrett D B
Treatment of imipramine-resistant recurrent depression: II. An open clinical trial of lithium augmentation.
The Journal of clinical psychiatry 1989;50(11):413-7.
1989: Thase M E; Kupfer D J; Jarrett D B
Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine.
The Journal of clinical psychiatry 1989;50(10):385-8.
1989: Reynolds C F; Thase M E; Jennings J R; Howell J R; Frank E; Berman S R; Houck P R; Kupfer D J
Nocturnal penile tumescence in healthy 20- to 59-year-olds: a revisit.
Sleep 1989;12(4):368-73.
1989: Thase M E; Himmelhoch J M; Mallinger A G; Jarrett D B; Kupfer D J
Sleep EEG and DST findings in anergic bipolar depression.
The American journal of psychiatry 1989;146(3):329-33.
1988: Thase M E; Reynolds C F; Jennings J R; Berman S R; Houck P R; Howell J R; Frank E; Kupfer D J
Diagnostic performance of nocturnal penile tumescence studies in healthy, dysfunctional (impotent), and depressed men.
Psychiatry research 1988;26(1):79-87.
1988: Reynolds C F; Frank E; Thase M E; Houck P R; Jennings J R; Howell J R; Lilienfeld S O; Kupfer D J
Assessment of sexual function in depressed, impotent, and healthy men: factor analysis of a Brief Sexual Function Questionnaire for men.
Psychiatry research 1988;24(3):231-50.
1988: Thase M E; Reynolds C F; Jennings J R; Frank E; Howell J R; Houck P R; Berman S; Kupfer D J
Nocturnal penile tumescence is diminished in depressed men.
Biological psychiatry 1988;24(1):33-46.
1987: Thase M E; Reynolds C F; Jennings J R; Frank E; Howell J; Houck P R; Kupfer D J
Do nocturnal penile tumescence recordings alter electroencephalographic sleep?
Sleep 1987;10(5):486-90.
1987: Campbell P I; Reynolds C F; Jennings J R; Thase M; Frank E; Howell J; Kupfer D J
Reliability of NPT scoring and visual estimates of erectile fullness.
Sleep 1987;10(5):480-5.
1987: Mallinger A G; Hanin I; Himmelhoch J M; Thase M E; Knopf S
Stimulation of cell membrane sodium transport activity by lithium: possible relationship to therapeutic action.
Psychiatry research 1987;22(1):49-59.
1987: Howell J R; Reynolds C F; Thase M E; Frank E; Jennings J R; Houck P R; Berman S; Jacobs E; Kupfer D J
Assessment of sexual function, interest and activity in depressed men.
Journal of affective disorders 1987;13(1):61-6.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Michael Thase

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Michael Thase (preview)

All Publications